Linder Roland, Horenkamp-Sonntag D, Bestmann B, Battmer U, Heilmann T, Verheyen F
WINEG - Wissenschaftliches Institut der TK für Nutzen und Effizienz im Gesundheitswesen, Bramfelder Straße 140, 22305, Hamburg, Deutschland,
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Apr;58(4-5):345-51. doi: 10.1007/s00103-015-2136-3.
After an introduction to the theme with an overview of the implementation of the Disease Management Programs (DMP), accompanying documentation, present utilization and costs of the programs, the present article is primarily devoted to the issue of the analysis of the benefits of DMP. Following an assessment of the legally specified evaluation requirements, in the absence of a prospective, randomized, controlled trial (RCT), the results of three studies are first summarized, which, with the application of propensity score matching, utilize the routine data of the statutory health insurance schemes to form a control group. The overview concludes with a look at the planned changes in evaluation and the intended expansion of the DMP to programs for other chronic illnesses.
在对疾病管理项目（DMP）的实施情况、相关文件、项目当前的利用率和成本进行概述以引入主题之后，本文主要致力于分析DMP的益处这一问题。在评估了法律规定的评估要求后，由于缺乏前瞻性、随机对照试验（RCT），首先总结了三项研究的结果，这些研究通过应用倾向得分匹配法，利用法定医疗保险计划的常规数据来形成一个对照组。概述最后展望了评估方面计划的变化以及DMP向其他慢性病项目的预期扩展。
